Shockwave Medical, Inc.【SWAV】

時価総額

PER

心血管向け医療機器の大手。IVLカテーテル（C2+、M5+、S4）を展開。2022年8月にC2+でMDR承認、2023年10月にM5+・S4で承認を取得。2023年純利益1億4730万ドル、2022年2億1600万ドルを計上。米国・欧州・日本を含む55か国超で展開。

株価業績

サマリーテーブルに戻る

	2019年 12月31日	2020年 12月31日	2021年 12月31日	2022年 12月31日	2023年 12月31日
Net income (loss)	-51	-66	-9	216	147
Depreciation and amortization	-	-	-	5	10
Loss from equity method investment	-	-	-6	-2	-2
Stock-based compensation	4	10	27	45	73
Non-cash lease expense	-	-	-	3	3
Amortization of premium and discount on available-for-sale securities	1	-0	-1	0	12
Loss on write down of fixed assets	0	0	0	0	0
Loss on extinguishment of debt	-	-	-	-1	-1
Deferred income taxes	-	-	-	-97	15
Amortization of debt issuance costs	0	1	1	1	2
Foreign currency remeasurement	-	-	-	-1	1
Accounts receivable	5	4	26	33	42
Inventory	7	17	12	30	31
Prepaid expenses and other current assets	1	1	2	4	3
Other assets	-0	0	-0	3	4
Accounts payable	1	-1	2	2	0
Accrued and other current liabilities	8	4	22	12	33
Lease liabilities	-	-	-	-2	2
Increase (Decrease) in Income Taxes Payable	-	-	-	-	2
Net cash provided by operating activities	-48	-71	15	118	196
Purchase of available-for-sale securities	119	168	117	138	747
Proceeds from maturities of available-for-sale securities	64	72	156	101	247
Purchase of property and equipment	4	12	12	25	31
Payments to Acquire Businesses, Net of Cash Acquired	-	-	-	-	94
Net cash (used in) provided by investing activities	-60	-107	26	-62	-626
Payments of taxes withheld on net settled vesting of restricted stock units	-	1	8	0	0
Proceeds from debt financing	-	-	-	-	80
Proceeds from Convertible Debt	-	-	-	-	730
Purchases of capped calls related to convertible debt	-	-	-	-	96
Payment For Assumed Warrant Liabilities	-	-	-	-	16
Proceeds from stock option exercises	2	4	3	3	1
Proceeds from issuance of common stock under employee stock purchase plan	-	-	-	4	6
Repayments of long-term debt	-	-	-	18	105
Net cash provided by (used in) financing activities	208	90	-2	13	600
Effect of exchange rate changes on cash and cash equivalents	-	-	-	-1	1
Net increase in cash, cash equivalents and restricted cash	100	-89	39	67	172
Interest paid	1	1	1	1	2
Income tax paid	0	0	0	2	8
Right-of-use asset obtained in exchange for lease liability	7	0	22	8	0
Capital Expenditures Incurred but Not yet Paid	0	2	2	6	4
Equity method investment obtained in exchange for related party contract liability	-	-	12	-	-